In this segment from Tuesday's Investor Beat, Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index (IBB -0.47%), and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight on what these warning signs are, and whether or not the bubble could be near collapse.
Why We're Watching This Biotech Index
By Chris Hill – Mar 26, 2014 at 3:30AM
iShares Trust - iShares Biotechnology ETF
Price as of March 30, 2023, 10:00 a.m. ET
Biotech has all the signs of a bubble right now, and many fear that it's about to burst.
Chris Hill has no position in any stocks mentioned. Morgan Housel has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Our Most Popular Articles
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.